Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, December 08, 2014
This award is recognition of both Pierre Fabre's expertise in dermatology, one of its development priorities, and of its ability to form public-private partnerships, such as that established with the University of Bordeaux.
read more
Tuesday, October 10, 2017
Piramal announced investments of $55 million across its sites in North America & Asia, to expand its API manufacturing capabilities and capacities.
read more
Tuesday, December 08, 2020
Piramal Pharma Limited has announced plans to expand its facility in Michigan with additional capacity and new capabilities for the development and manufacturing of APIs.
read more
Piramal has entered into an agreement with G&W Laboratories to acquire its solid oral dosage drug product manufacturing facility located in Sellersville, Pennsylvania.
read more
Piramal Pharma Limited’s Pharma Solutions business announced that the company’s site in Digwal in the state of Telangana, India, has implemented various tools to unlock Active Pharmaceutical Ingredient (API) manufacturing capacity and support client ...
read more
Piramal Pharma Limited's Pharma Solutions business announced that a new active pharmaceutical ingredient (API) plant at the company's site in Aurora, Ontario, has come online and successfully completed its initial production runs.
read more
Tuesday, January 14, 2025
With this move, PLD is consolidating its divisions with a unified identity that reflects the company’s commitment to developing and manufacturing high quality, liquid and solid dose OTC and Rx products to its customers.
read more
Wednesday, December 06, 2017
Plasticell announced it will collaborate with Anthony Nolan to progress clinical development of Plasticell’s ex vivo expanded cord-blood derived hematopoietic stem cell product.
read more
The PolyPeptide Group has partnered with Novavax on large-scale GMP production of a critical component of Novavax’ novel coronavirus vaccine candidate, NVX-CoV2373.
read more
Codexis and Porton Pharma announce a collaboration to deploy Codexis’ biocatalyst technology within Porton’s global custom intermediate and API development and manufacturing business.
read more
Monday, September 07, 2020
PPD and LT have entered into a collaboration to expand and enhance lupus clinical research for PPD’s pharmaceutical and biotech customers.
read more
Precision Dose is voluntarily recalling all lots of Chlorhexidine Gluconate Oral Rinse USP, 0.12%, 15mL Unit Dose Cups to the consumer level.
read more
Processa has entered into a licensing agreement with Yuhan, a South Korean based company, to license in YH12852.
read more
SpineThera, Inc., a clinical-stage pharmaceutical company focused on the development of SX600 (a novel formulation of extended-release dexamethasone microspheres for epidural injection for the management of lumbar radicular pain) and ProMed Pharma ...
read more
Tuesday, November 03, 2020
Protagonist Therapeutics announced two additional oral peptide IL-23 receptor antagonist candidates from its collaboration agreement with Janssen Biotech have been selected for advancement into clinical development.
read more